Eugene

[email protected]

LATEST

US House Committee Provides Measures to Improve Drug-Pricing Program
By

By
The US House of Representatives’ House Energy & Commerce (E&C) Committee has released a report to offer recommendations to improve the 340B Drug Discount Program, a US federal government program…

FDA Commissioner Outlines Steps to Enhance Transparency of Clinical Trial Info
By

By
The US Food and Drug Administration (FDA) Commissioner Scott Gottlieb has outlined steps to enhance transparency of clinical trial information to support scientific inquiry related to new drugs. “We’re especially…

FDA Commissioner Provides Update on IV Fluid Shortages in Puerto Rico
By

By
The US Food and Drug Administration (FDA) Commissioner Scott Gottlieb has issued an update on IV fluid shortages in Puerto Rico following Hurricanes Irma and Maria. This follows a January…

Eisai Completes Construction of Solid-Dosage Plant in China
By

By
Eisai has completed construction of a new oral solid-dosage (OSD) production facility and an administration building at the site of its new Suzhou, China plant located within the Suzhou Industrial…

Chinese Antibiotic Manufacturer Cited for GMP Violations
By

By
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has issued to Inner Mongolia Changsheng Pharmaceutical, a Hohhot, China-headquartered pharmaceutical company, a statement of non-compliance with good manufacturing practice (GMPs)…

FDA Commissioner Updates Efforts to Increase Access to Complex Generic Drugs
By

By
The US Food and Drug Administration (FDA) Commissioner Scott Gottlieb has responded to a US Government Accountability Office (GAO) report, regarding the FDA’s development of a better approach for the…

Swedish Biopharma Company Xbrane Plans Launch of Biosimilar to Roche’s Lucentis
By

By
Xbrane Biopharma, a Stockholm, Sweden-headquartered biopharmaceutical company, has signed a non-binding letter of intent with CR Pharma, a Beijing, China-headquartered pharmaceutical company, regarding licensing Xlucane (ranibizumab), a biosimilar of Roche’s…

Novartis Leads Pipeline News
By

By
A roundup of the latest market developments from the pipelines of the pharmaceutical majors, featuring news from Novartis. Editor’s Note: This article was updated on a continuous basis for news…

Quotient Sciences, PPD Partner in Pediatric Drug Development
By

By
Pharmaceutical Product Development (PPD), a Wilmington, North Carolina-headquartered contract research organization, and Quotient Sciences, a Nottingham, UK-based contract development and manufacturing organization, have partnered in pediatric drug development. The partnership…

Nitto Avecia Appoints President
By

By
Nitto Avecia Pharma Services, a Milford, Massachusetts-headquartered provider of nucleic acid manufacturing and development services, has appointed Raymond Kaczmarek as president. Kaczmarek will have full profit and loss responsibility for…